The predominant side effects include: Gastrointestinal symptoms : nausea, vomiting, diarrhoea, constipation, and abdominal pain (affecting 10-50% of patients depending on the specific product and dose, particularly during dose escalation) Injection site reactions : redness, itching, or discomfort at the subcutaneous injection site Hypoglycaemia : particularly when combined with insulin or sulphonylureas Decreased appetite : an intended therapeutic effect that contributes to weight loss However, some patients do report changes in urinary frequency or patterns
Applicable Procedure Codes: 69930, L8614, L8615, L8616, L8617, L8618, L8619, L8627, L8628, V5273
Peptides are chemically sensitive materials, and reconstitution behaviour can be influenced by the exact diluent used
We can pay cash for name-brand semaglutide, which costs a small fortune, or pay for compounded semaglutide, which is not FDA approved but is much more affordable and can be purchased from reputable online clinics